Complete Filing Data
Lotus Technology Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of -$860.23 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lotus Technology Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income * | -$1.10B | -$742.0M | -$723.9M | -$110.5M |
| Selling And Marketing Expense | $322.3M | $328.9M | $151.3M | $38.1M |
| Revenue From Contract With Customer Excluding Assessed Tax | $924.3M | $679.0M | $9.6M | $3.7M |
| Research And Development Expense | $274.8M | $368.7M | $445.8M | $511.4M |
| Other Comprehensive Income Loss Net Of Tax | $29.9M | $7.6M | $17.8M | -$724.0K |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $16.4M | $16.2M | $18.7M | -$843.0K |
| Other Comprehensive Income Loss Financial Liability Fair Value Option Reclassification Adjustment From Aoci For Derecognition Tax | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Financial Liability Fair Value Option Reclassification Adjustment From Aoci For Derecognition After Tax | -$13.5M | $8.7M | $893.0K | -$119.0K |
| Operating Income Loss | -$786.3M | -$735.9M | -$687.4M | -$112.9M |
| Operating Expenses | $815.9M | $838.1M | $689.7M | $113.5M |
| Net Income Loss Available To Common Stockholders Basic | -$1.11B | -$757.1M | -$724.8M | -$110.5M |
| Interest Expense | $58.2M | $10.2M | $8.5M | $3.6M |
| Income Taxes Paid | $678.0K | $1.2M | $1.8M | $62.0K |
| Income Tax Expense Benefit | $2.0M | $1.1M | $292.0K | $1.9M |
| Gross Profit | $29.6M | $102.2M | $2.3M | $557.0K |
| General And Administrative Expense | $227.5M | $144.5M | $148.4M | $54.8M |
| Cost Of Revenue | $894.7M | $576.8M | $7.3M | $3.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$1.08B | -$742.7M | -$706.8M | -$111.3M |
| Comprehensive Income Net Of Tax | -$1.08B | -$734.4M | -$706.1M | -$111.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.11B | -$749.1M | -$724.3M | -$108.7M |
| Net Income Loss Attributable To Noncontrolling Interest | -$2.4M | -$8.3M | -$642.0K | |
| Income Loss From Equity Method Investments | -$171.0K | -$1.0M | -$2.8M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$2.4M | -$8.3M | -$642.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Stockholders Equity * | -$852.9M | -$1.21B | -$452.4M | $195.3M | $16.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $484.9M | $427.1M | $739.5M | $531.5M | $45.7M |
| Deferred Income | $293.9M | $270.1M | $258.5M | $340.3M | $541.6M |
| Cash And Cash Equivalents At Carrying Value | $103.1M | $418.9M | $736.6M | $531.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $57.8M | -$312.4M | $208.1M | $485.8M | |
| Restricted Cash And Cash Equivalents Noncurrent | $2.6M | $321.0K | $536.0K | ||
| Restricted Cash And Cash Equivalents At Carrying Value | $379.3M | $7.9M | $2.4M | ||
| Temporary Equity Accretion To Redemption Value Adjustment | $3.0M | $15.1M | $910.0K | ||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $3.0M | $15.1M | $910.0K | ||
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $31.7M | $15.5M | $38.5M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $18.3M | $20.1M | $15.4M | $5.6M | |
| Gain Loss On Sale Of Investments | $14.2M | -$1.2M | -$3.2M | $2.2M | |
| Retained Earnings Accumulated Deficit | -$2.69B | -$1.59B | -$846.8M | ||
| Operating Lease Right Of Use Asset | $144.0M | $173.1M | $158.7M | ||
| Minority Interest | -$7.4M | -$5.4M | -$642.0K | ||
| Liabilities Noncurrent | $678.5M | $654.6M | $523.7M | ||
| Liabilities Current | $2.47B | $1.76B | $932.9M | ||
| Liabilities And Stockholders Equity | $2.29B | $1.58B | $1.37B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Proceeds From Sale Of Productive Assets | $6.5M | $5.1M | $1.1M | $14.0K |
| Payments To Acquire Productive Assets | $57.3M | $213.7M | $133.3M | $34.6M |
| Net Cash Provided By Used In Operating Activities | -$848.5M | -$386.9M | -$351.4M | -$126.5M |
| Net Cash Provided By Used In Investing Activities | -$579.4M | -$198.0M | -$149.4M | $244.5M |
| Net Cash Provided By Used In Financing Activities | $1.46B | $284.7M | $758.1M | $364.9M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $26.2M | -$12.2M | -$49.2M | $2.9M |
| Proceeds From Income Tax Refunds | $127.0K | $45.0K | $131.0K | $30.0K |
| Proceeds From Issuance Of Exchangeable Notes | $28.5M | $27.9M | $379.0M | $125.0M |
| Proceeds From Sales Of Short Term Investments | $48.3M | $37.4M | $289.6M | |
| Payments To Acquire Equity Method Investments | $414.0K | $5.1M | $3.1M | |
| Payments For Purchases Of Short Term Investments | $48.2M | $38.3M | $300.7M | |
| Proceeds From Government Grant Related To Assets | $28.1M | $16.3M | $279.1M | |
| Increase Decrease In Operating Lease Liability | -$16.4M | -$29.4M | -$14.6M | -$55.4M |
| Increase Decrease In Inventories | -$69.7M | $235.1M | $21.6M | $2.0M |
| Increase Decrease In Contract With Customer Liability | -$7.2M | $42.4M | $6.3M | $1.9M |
| Depreciation Depletion And Amortization | $76.5M | $55.0M | $12.8M | $2.1M |
| Share Based Compensation | $31.9M | $10.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Common Stock Shares Authorized | 5.00B | 5.00B | 5.00B | 5.00B |
| Weighted Average Number Of Shares Outstanding Basic | 645.2M | 474.6M | 475.8M | 334.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 645.2M | 474.6M | 475.8M | 334.1M |
| Earnings Per Share Basic | $-1.72 | $-1.60 | $-1.52 | $-0.33 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Diluted | $-1.72 | $-1.60 | $-1.52 | $-0.33 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Investment Income Net | $14.2M | -$1.2M | -$3.2M | $2.2M |
| Interest Income Operating | $22.3M | $9.2M | $12.2M | $6.2M |
| Foreign Currency Transaction Gain Loss Before Tax | -$11.7M | $42.0K | -$11.5M | $798.0K |
| Changes In Fair Values Of Mandatorily Redeemable Noncontrolling Interest Exchangeable Notes And Convertible Notes Excluding Impact Of Instrument Specific Credit Risk | -$285.4M | -$10.0M | -$23.0M | -$1.4M |
| Capital Expenditures Incurred But Not Yet Paid | $70.9M | $71.1M | $108.0M | $18.3M |
| Interest Paid Net | $8.1M | $8.1M | $471.0K | |
| Accretion Of Redeemable Convertible Preferred Shares | 3.0M | 15.1M | 910.0K | |
| Product Warranty Expense | $21.9M | $8.5M | $0.00 | $0.00 |
| Paid In Kind Interest | $14.8M | $1.6M | $8.2M | $3.6M |
| Government Assistance Operating Income | $8.6M | $4.1M | $55.8M | |
| Foreign Currency Transaction Gain Loss Unrealized | -$496.0K | -$1.5M | -$10.2M | $694.0K |
| Fair Value Adjustment Of Mandatorily Redeemable Noncontrolling Interest Exchangeable Notes And Convertible Notes | -$285.4M | -$10.0M | -$23.0M | -$1.4M |
| Short Term Borrowings | $802.5M | $226.8M | $28.7M | |
| PIC Share Based Payment Arrangement Issuance Of Exchangeable Notes Increase For Cost Recognition | $909.0K | $8.1M | $3.4M |
Most recent annual filing with the SEC: April 30, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.